EpiVax is a privately-held biotechnology company based in Providence, RI that is dedicated to the development and implementation of computational immunology tools to benefit the biotechnology industry. Since 1998 we have developed extensive expertise and a proven track record of immunogenicity screening, immune modulation, vaccine design and biologics risk management.